Sclerostin is an osteocyte-expressed negative regulator of bone formation.

被引：0
|
作者：
Lowik, C [1 ]
ten Dijke, P [1 ]
van Bezooijen, R [1 ]
机构：
[1] Leiden Univ, Med Ctr, NL-2300 RA Leiden, Netherlands
来源：
BONE | 2003年 / 33卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S19 / S19
页数：1
相关论文
共 50 条
  • [1] Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist
    van Bezooijen, RL
    Roelen, BAJ
    Visser, A
    van der Wee-Pals, L
    de Wilt, E
    Karperien, M
    Hamersma, H
    Papapoulos, SE
    ten Dijke, P
    Löwik, CWGM
    JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (06): : 805 - 814
  • [2] SCLEROSTIN IS AN OSTEOCYTE-EXPRESSED NEGATIVE REGULATOR OF BONE FORMATION, BUT NOT A CLASSICAL BMP ANTAGONIST
    Lowik, C.
    Ten Dijke, P.
    Van Bezooijen, R.
    CALCIFIED TISSUE INTERNATIONAL, 2004, 74 : S22 - S22
  • [3] Increasing levels of serum sclerostin, an osteocyte-expressed negative regulator of bone formation, are associated with atherosclerotic disease in type 2 diabetes
    Morales, S.
    Garcia-Fontana, B.
    Garcia-Martin, A.
    Rozas-Moreno, P.
    Garcia-Salcedo, J. A.
    Reyes-Garcia, R.
    Munoz-Torres, M.
    BONE, 2012, 50 : S175 - S175
  • [4] Sclerostin: An osteocyte-expressed BMP antagonist the inhibits bone formation by mature osteoblasts.
    Van Bezooijen, RL
    Winkler, D
    Hayes, T
    Karperien, M
    Visser, A
    van der Wee-Pals, L
    Hamersma, H
    Papapoulos, SE
    Latham, JA
    Lowik, CWG
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S144 - S144
  • [5] SOST/sclerostin, an osteocyte-derived negative regulator of bone formation
    Bezooijen, RL
    ten Dijke, P
    Papapoulos, SE
    Löwik, CWGM
    CYTOKINE & GROWTH FACTOR REVIEWS, 2005, 16 (03) : 319 - 327
  • [6] Vitamin D is a negative regulator of the excessive bone formation.
    Tanaka, H
    Kinuta, K
    Inoue, N
    Shinohara, M
    Kato, S
    Seino, Y
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S230 - S231
  • [7] Biglycan: a negative regulator of channel formation.
    Rapoport, O
    Ameve, I
    Septier, D
    Palmier, K
    Young, M
    Goldberg, M
    JOURNAL OF DENTAL RESEARCH, 2002, 81 : B277 - B277
  • [8] Osteocyte control of bone formation via sclerostin, a novel BMP antagonist
    Winkler, DG
    Sutherland, MK
    Geoghegan, JC
    Yu, CP
    Hayes, T
    Skonier, JE
    Shpektor, D
    Jonas, M
    Kovacevich, BR
    Staehling-Hampton, K
    Appleby, M
    Brunkow, ME
    Latham, JA
    EMBO JOURNAL, 2003, 22 (23): : 6267 - 6276
  • [9] Osteocyte sclerostin expression: Regulator of BMU balance in osteoarthritis and osteoporosis?
    Loveridge, N.
    Power, J.
    Caballero-Alias, A.
    van Bezooijen, R.
    Papapoulos, S.
    Lowik, C.
    Poole, K. E.
    Reeve, J.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 (07) : 1114 - 1114
  • [10] Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption–formation cycles?
    R. Sapir-Koren
    G. Livshits
    Osteoporosis International, 2014, 25 : 2685 - 2700
12345